Related Experiment Video
Updated: Apr 7, 2026

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
Published on: September 22, 2011
Leveraging analytical and bioprocess platforms for biological product development and commercialization - A meeting
Shawn Novick1, Mihai Bilanin2, Mihaela Buda3
1IABS, Rue de l'Est 8, CH-1207, Geneva, Switzerland.
Abstract:
In May 2025, the International Alliance for Biological Standardization (IABS) held a workshop on analytical and bioprocess platforms for biological product development and commercialization. This workshop explored the use of platform approaches and technologies in product development and registration. The topics discussed included the creation, verification, and maintenance of platform technologies, their lifecycle management, their application in regulatory submissions, and the transition from early clinical trials to commercial approval. The participants highlighted the importance of clearly defining the boundaries and applicability of platform approaches in pharmaceutical development. A consistent and open dialogue between industry stakeholders, regulatory reviewers, and health authorities is essential to ensure a shared understanding and alignment in defining the platform landscape.
Related Concept Videos
Upstream Processing
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Bioreactor Design and Operational System
Drug Products: Biologics, Biosimilars and Interchangeables
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Production of Pharmaceuticals

